04470nam 2200601Ia 450 991013987540332120180727114308.01-282-33160-497866123316021-4443-0846-71-4443-0847-5(CKB)1000000000807261(EBL)547043(OCoLC)646788356(SSID)ssj0000310227(PQKBManifestationID)11239011(PQKBTitleCode)TC0000310227(PQKBWorkID)10286712(PQKB)11109624(MiAaPQ)EBC547043(PPN)194581497(EXLCZ)99100000000080726120090202d2009 uy 0engur|n|---|||||rdacontentrdamediardacarrierStaphylococci in human disease[electronic resource] /edited by Kent B. Crossley ... [et al.]2nd ed.Chichester, West Sussex ;Hoboken, NJ Wiley-Blackwell20091 online resource (647 p.)Description based upon print version of record.1-4051-6332-1 Includes bibliographical references and index.Staphylococci inHuman Disease; Contents; Contributors; Preface to the Second Edition; Section IThe Organisms; Biology and Taxonomy; Chapter 1The Biology of Staphylococci; Chapter 2Genomics of the Staphylococci; Chapter 3Evolution and Taxonomyof Staphylococci; Chapter 4Molecular Basis of Pathogenicity; Chapter 5Adaptation to Stress: Biofilms andSmall-colony Variants; Chapter 6Exotoxins; Chapter 7Host Defense Against StaphylococcalInfection; Antimicrobial Resistance inStaphylococci; Chapter 8Resistance to b -Lactam Antibiotics; Chapter 9Resistance to GlycopeptidesChapter 10Resistance to Other AgentsLaboratory Studies; Chapter 11Issues in the Identification andSusceptibility Testing of Staphylococci; Section IIEpidemiology of StaphylococcalInfection; Chapter 12Colonization with Staphylococcusaureus and the Role of Colonizationin Causing Infection; Chapter 13Epidemiology of Community-associatedStaphylococcus aureus Infections; Chapter 14Epidemiology of Healthcare-associatedStaphylococcus aureus Infections; Chapter 15Epidemiology of Coagulase-negativeStaphylococci and Infections Causedby these Organisms; Section IIIDiseases Caused by StaphylococciChapter 16Staphylococcus aureus Bacteremiaand EndocarditisChapter 17Surgical-site Infections andSurgical Prophylaxis; Chapter 18Infections of Intravascular Cathetersand Vascular Devices; Chapter 19Skin and Soft Tissue Infections; Chapter 20Central Nervous System Infections; Chapter 21Diseases of the Eye; Chapter 22Osteomyelitis and Other Bone andJoint Infections; Chapter 23Staphylococcal Pneumonia; Chapter 24Urinary Tract Infections; Chapter 25Toxic Shock Syndrome; Chapter 26Toxin-mediated Syndromes; Chapter 27Staphylococcal Diarrhea andEnterocolitisChapter 28Infections in ImmunocompromisedPatientsChapter 29Clinical Manifestations of Community-acquiredMRSA Infections; Section IVPrevention and Treatment ofStaphylococcal Infections; Chapter 30Elimination of Staphylococcus aureusCarriage: Importance and Strategies; Chapter 31Treatment of Staphylococcal Infection; Chapter 32Vaccine-based Strategies for Preventionof Staphylococcus aureus Infection; Index; PlatesStaphylococci remain the most important cause of hospital-acquired infections in the U.S. and MRSA has become the most common cause of skin and soft tissue infection in many parts of the world. There is now a much greater understanding of the physiology and evolution of the staphylococci and this new edition reflects the rapid advancements in knowledge about this pathogen and provides a comprehensive review from both clinical and basic science perspectives. The first section addresses the basic biology of the staphylococci, their molecular genetics, host defenses and host evasion, virulencStaphylococcal infectionsGram-positive bacterial infectionsStaphylococcal infections.Gram-positive bacterial infections.616.9297Crossley Kent B867729MiAaPQMiAaPQMiAaPQBOOK9910139875403321Staphylococci in human disease1936828UNINA